Showing results (61-70 of 145) with videos related to
Sort By:
Pageof 15
Annals of the Rheumatic Diseases|October 14, 2004
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infectionL H Calabrese, N Zein, D VassilopoulosPathogens & Immunity|May 10, 2021
The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?N Winchester, C Calabrese, L H CalabreseCleveland Clinic Journal of Medicine|March 1, 1990
Urticaria, nephritis, and pseudotumor cerebriJ Lieberman, G Gephardt, L H CalabreseThe American Journal of Sports Medicine|September 28, 2001
Valgus laxity of the ulnar collateral ligament of the elbow in collegiate athletesH Singh, D C Osbahr, M Q Wickham, et al.Clinical Biomechanics (Bristol, Avon)|June 8, 2001
A comparison of knee joint motion patterns between men and women in selected athletic tasksR A Malinzak, S M Colby, D T Kirkendall, et al.British Journal of Sports Medicine|June 25, 2005
Injury history as a risk factor for incident injury in youth soccerK L Kucera, S W Marshall, D T Kirkendall, et al.The Laryngoscope|July 17, 1998
Dysphagia in patients with inclusion body myositisS M Houser, L H Calabrese, M StromeRheumatic Diseases Clinics of North America|February 1, 1995
Therapy of resistant systemic necrotizing vasculitis. Polyarteritis, Churg-Strauss syndrome, Wegener's granulomatosis, and hypersensitivity vasculitis group disordersL H Calabrese, G S Hoffman, L GuillevinArthritis and Rheumatism|April 1, 1987
Inclusion body myositis presenting as treatment-resistant polymyositisL H Calabrese, H Mitsumoto, S M ChouAnnals of the Rheumatic Diseases|April 22, 2006
Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategiesL H Calabrese, N N Zein, D VassilopoulosPageof 15